🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "targeted measures to address household expense pressures" in the upcoming financial statement.

During an interview with media outlets, she emphasized that curbing price rises is a collective duty of both the government and the central bank.

The UK's price growth is projected to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Possible Energy Bill Measures

Sources suggest the government could take action to reduce energy bills, for instance by reducing the present 5% rate of value-added tax applied on energy.

Another option is to reduce some of the government charges presently added to household expenses.

Budgetary Constraints and Analyst Expectations

The government will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these actions.

The view from most analysts is that Reeves will have to introduce tax increases or budget cuts in order to adhere to her declared borrowing rules.

Previously on the same day, estimates showed there was a £22bn deficit for the chancellor to resolve, which is at the lower end of projections.

"It is a collective task between the central bank and the government to bear down further on some of the drivers of price increases," the Chancellor stated to the BBC in Washington, at the conferences of the IMF and global financial institution.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on likely tax increases, the chancellor said the most recent data from the fiscal watchdog had not changed her commitment to election pledges not to raise rates on earnings tax, VAT or National Insurance.

She blamed an "uncertain global environment" with rising geopolitical and trade tensions for the Budget revenue measures, probably to be focused on those "wealthiest."

International Economic Tensions

Referring to concerns about the UK's commercial links with China she said: "The UK's security interests invariably come first."

Last week's declaration by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are key for high-technology production led American leader Donald Trump to propose an additional 100% tariff on goods from the Asian country, raising the risk of an all-out commercial conflict between the two global powers.

The American finance chief called the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on accepting the American proposal to join its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the global economy and creates further challenges."

"I believe there are areas where we should address Chinese policies, but there are also valuable prospects to trade with China's economy, including banking sector and other sectors of the economic system. We've got to achieve that balance right."

The chancellor also stated she was working with G7 counterparts "regarding our own essential resources strategy, so that we are more independent."

Health Service Medicine Costs and Funding

Reeves also acknowledged that the price the NHS spends on pharmaceuticals could go up as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the world's largest drug companies have said recently that they are either pausing or scrapping operations in the United Kingdom, with some blaming the insufficient payments they are getting.

Recently, the government science advisor said the price the NHS spends on drugs would must rise to prevent businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor informed the BBC: "We have seen due to the payment system, that drug testing, innovative medicines have not been available in the United Kingdom in the way that they are in other EU nations."

"The objective is to ensure that individuals getting care from the National Health Service are can obtain the top life-saving treatments in the globe. And so we are reviewing this situation, and... looking to attract additional funding into the UK."